Change language

Sidebar content	Main content
Actions Displays	Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis. Technology Appraisal Guidance - no. 36. 2002 Remove from selection Add to selection TitleGuidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis. Technology Appraisal Guidance - no. 36. 2002 Author NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE PublisherNATIONAL INSTITUTE FOR CLINICAL EXCELLENCE Year of publication2002 DimensionsA4 MaterialBook MaterialBook SubjectARTHRITIS, chronic, DRUGS - PROPRIETARY MEDICINE, RHEUMATIC DISEASE

Main content

Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis. Technology Appraisal Guidance - no. 36. 2002

Add to selection

TitleGuidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis. Technology Appraisal Guidance - no. 36. 2002

Author

Year of publication2002

DimensionsA4

MaterialBook

AIS uses strictly necessary cookies to improve the user experience.

This AIS also uses analytical cookies.